HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin Zhou Selected Research

4,2'- difluoro- 5'- (8- fluoro- 7- (1- hydroxy- 1- methylethyl)imidazo(1,2- a)pyridin- 3- yl)biphenyl- 2- carbonitrile

5/2009A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin Zhou Research Topics

Disease

128Neoplasms (Cancer)
09/2022 - 10/2002
39Acute Promyelocytic Leukemia
12/2021 - 11/2003
22Stomach Neoplasms (Stomach Cancer)
01/2022 - 08/2008
21Neoplasm Metastasis (Metastasis)
09/2022 - 05/2005
21Breast Neoplasms (Breast Cancer)
01/2022 - 05/2005
20Inflammation (Inflammations)
11/2022 - 06/2004
19Carcinogenesis
01/2022 - 01/2003
16Myocardial Infarction
01/2022 - 05/2010
15Infections
01/2022 - 07/2003
14Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 04/2012
13Leukemia
10/2021 - 11/2003
11Thrombosis (Thrombus)
07/2021 - 09/2008
11Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2021 - 06/2007
10Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2020 - 10/2011
10Hypoxia (Hypoxemia)
10/2019 - 09/2002
9Hepatocellular Carcinoma (Hepatoma)
09/2022 - 10/2007
9Infarction (Infarctions)
01/2022 - 04/2010
9Non-alcoholic Fatty Liver Disease
01/2022 - 04/2014
9Pancreatic Neoplasms (Pancreatic Cancer)
09/2021 - 05/2009
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018 - 02/2010
8Fibrosis (Cirrhosis)
11/2022 - 02/2015
8Multiple Myeloma
12/2021 - 07/2007
8Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 12/2011
8Stroke (Strokes)
12/2020 - 05/2006
8Hemorrhage
10/2020 - 12/2011
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 11/2013
8Ischemia
01/2017 - 09/2002
7Necrosis
04/2022 - 12/2004
7Wounds and Injuries (Trauma)
04/2022 - 05/2010
7Type 2 Diabetes Mellitus (MODY)
01/2022 - 04/2008
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2013
7Carcinoma (Carcinomatosis)
09/2021 - 01/2015
7Adenocarcinoma
12/2020 - 06/2005
7Brain Ischemia (Cerebral Ischemia)
03/2015 - 07/2004
6Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2006
6Lung Neoplasms (Lung Cancer)
01/2020 - 01/2017
5Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 10/2016
5Residual Neoplasm
01/2022 - 12/2003
5Hypertension (High Blood Pressure)
01/2022 - 07/2005
5Pheochromocytoma
04/2020 - 10/2002
5Pain (Aches)
01/2019 - 07/2010
5Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 11/2015
5Body Weight (Weight, Body)
01/2018 - 04/2006
5Splenomegaly
01/2013 - 11/2011
4Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 08/2016

Drug/Important Bio-Agent (IBA)

43Arsenic Trioxide (Trisenox)FDA Link
12/2021 - 11/2003
42Proteins (Proteins, Gene)FDA Link
09/2022 - 05/2007
24Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2006
20MicroRNAs (MicroRNA)IBA
01/2022 - 05/2007
18Pharmaceutical PreparationsIBA
09/2022 - 08/2006
17Biological ProductsIBA
01/2021 - 02/2002
16ArsenicIBA
07/2021 - 11/2003
15Messenger RNA (mRNA)IBA
01/2022 - 10/2002
14PhosphatidylserinesIBA
01/2020 - 07/2009
12Cisplatin (Platino)FDA LinkGeneric
10/2019 - 06/2007
10EnzymesIBA
01/2022 - 06/2007
10Inosine Triphosphate (ITP)IBA
09/2020 - 05/2005
9Epidermal Growth Factor (EGF)IBA
01/2022 - 06/2005
9CytokinesIBA
02/2020 - 01/2007
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2002
8Peptides (Polypeptides)IBA
01/2022 - 04/2008
8Transcription Factors (Transcription Factor)IBA
01/2022 - 06/2007
8CholesterolIBA
01/2021 - 01/2014
8HydrogelsIBA
06/2020 - 04/2010
8DNA (Deoxyribonucleic Acid)IBA
01/2018 - 05/2007
8Aligeron (AS 2)IBA
05/2011 - 11/2003
7Therapeutic UsesIBA
01/2022 - 08/2004
7Thyroid HormonesIBA
01/2022 - 07/2012
7Phosphotransferases (Kinase)IBA
01/2022 - 11/2012
7Small Interfering RNA (siRNA)IBA
01/2022 - 07/2010
6Interleukin-6 (Interleukin 6)IBA
04/2021 - 05/2012
6CollagenIBA
01/2021 - 02/2008
6Chimeric Antigen ReceptorsIBA
01/2021 - 02/2018
6Oxygen (Dioxygen)IBA
01/2018 - 09/2002
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2022 - 03/2012
5Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 10/2013
5Fluorescent Dyes (Fluorescent Probes)IBA
02/2022 - 03/2015
5Circular RNAIBA
01/2022 - 12/2018
5Long Noncoding RNAIBA
01/2022 - 01/2018
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 03/2006
5CalciumIBA
06/2020 - 10/2004
5DecitabineFDA Link
01/2018 - 10/2014
5PlatinumIBA
01/2018 - 05/2013
5IntegrinsIBA
10/2017 - 10/2006
5Angiotensin IIIBA
02/2017 - 06/2004
4Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2015
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022 - 10/2004
4Triglycerides (Triacylglycerol)IBA
12/2021 - 01/2014
4Drinking WaterIBA
12/2021 - 01/2012

Therapy/Procedure

58Therapeutics
11/2022 - 11/2003
31Drug Therapy (Chemotherapy)
01/2022 - 05/2006
18Splenectomy
03/2014 - 10/2011
12Transplantation
07/2021 - 11/2010
8Injections
01/2021 - 05/2010
8Neoadjuvant Therapy
01/2020 - 01/2015
6Ligation
01/2022 - 09/2002
6Aftercare (After-Treatment)
01/2018 - 04/2006
5Immunotherapy
09/2022 - 08/2014
5Hematopoietic Stem Cell Transplantation
12/2021 - 10/2014
5Length of Stay
01/2019 - 11/2011